TokenPost·
Twist Bioscience Targets Up to $560 Million in FY2027 Revenue
The forecast includes $100 million from AI drug discovery and positive adjusted EBITDA for the full fiscal year.
More news
- TokenPostBinance Says It Has Covered $6.34 Billion in Hack Losses
- TokenPostTeam, Inc. Updates Fiscal 2026 Adjusted EBITDA Outlook to $56M-$59M
- Crypto BriefingGemini revenue falls 19% to $40.9M as crypto trading volume plunges
- TokenPostDoncasters Sets Fiscal 2027 Guidance, Signs Fifth Strategic Partnership
- TokenPostSpaceX-Linked Tokenized Products Lead Circle-Linked Peers by $8.64 Million
- TokenPostMicrosoft Ties Outlook Outage to Unexpected Server Disruptions